These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1706862)

  • 1. Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration.
    Elliott PJ; Paris JM; Mitsushio H; Lorens SA
    Pharmacol Biochem Behav; 1990 Oct; 37(2):329-33. PubMed ID: 1706862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance-P antagonists: effect on spontaneous and drug-induced locomotor activity in the rat.
    Elliott PJ; Iversen SD
    Neuropharmacology; 1987 May; 26(5):419-22. PubMed ID: 2439936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats.
    Placenza FM; Fletcher PJ; Rotzinger S; Vaccarino FJ
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):111-20. PubMed ID: 15167979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
    Altier N; Stewart J
    Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
    Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-VTA infusions of the substance P analogue, DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain.
    Altier N; Stewart J
    Brain Res; 1993 Nov; 628(1-2):279-85. PubMed ID: 7508809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.
    Kalivas PW; Burgess SK; Nemeroff CB; Prange AJ
    Neuroscience; 1983 Mar; 8(3):495-505. PubMed ID: 6406930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area.
    Barnes JM; Barnes NM; Costall B; Cox AJ; Domeney AM; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
    Eison AS; Eison MS; Iversen SD
    Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-midbrain raphe injections of the neurokinin-3 agonist senktide inhibit food and water intake in the rat.
    Paris JM; Mitsushio H; Lorens SA
    Pharmacol Biochem Behav; 1991 Jan; 38(1):223-6. PubMed ID: 1708148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of substance P through dopaminergic pathways in the brain.
    Iversen SD
    Ciba Found Symp; 1982; (91):307-24. PubMed ID: 6183078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-median raphe infusions of muscimol and the substance P analogue DiMe-C7 produce hyperactivity: role of serotonin neurons.
    Paris JM; Lorens SA
    Behav Brain Res; 1987; 26(2-3):139-51. PubMed ID: 2447909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1989 Jul; 33(3):595-9. PubMed ID: 2511575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of locomotor behavior following microinjections of muscimol into various sites in the paramedian tegmentum.
    Wirtshafter D; Klitenick MA
    Pharmacol Biochem Behav; 1989 Mar; 32(3):625-8. PubMed ID: 2740418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural effects of tachykinins and related peptides.
    Elliott PJ; Iversen SD
    Brain Res; 1986 Aug; 381(1):68-76. PubMed ID: 2428433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotor activation induced in rodent by substance P and analogues. Blockade of the effect of substance P by met-enkephalin antiserum.
    Naranjo JR; Del Rio J
    Neuropharmacology; 1984 Oct; 23(10):1167-71. PubMed ID: 6084200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.